1,937 results on '"A. Vaporciyan"'
Search Results
102. Telomere Length and Recurrence Risk after Curative Resection in Patients with Early-Stage Non–Small-Cell Lung Cancer: A Prospective Cohort Study
103. 280 Clinical outcomes of immunotherapy continued beyond radiographic progression in older adults with advanced non-small cell lung cancer
104. 962 Integrative immunomics highlight the immunomodulatory impact of neoadjuvant chemotherapy and immune-based treatments in resected non-small-cell lung cancer
105. 174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes
106. Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
107. American Board of Thoracic Surgery 10-Year Maintenance of Certification Exam Improves and Validates Knowledge Acquisition
108. Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non–small cell lung cancer
109. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma
110. E-Learning Trends and How to Apply Them to Thoracic Surgery Education
111. How to Give Effective Formative Feedback in Thoracic Surgery Education
112. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience
113. Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic
114. Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review
115. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases
116. Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing
117. Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non–Small-Cell Lung Cancer Data Set
118. Comprehensive T cell repertoire characterization of non-small cell lung cancer
119. Thoracic Surgical Oncology Group: An American Association for Thoracic Surgery Clinical Trials Initiative
120. Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations
121. Octreotide's role in the management of post-esophagectomy chylothorax.
122. Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm
123. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery
124. Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non–small cell lung cancer
125. OA22.04 BRIGHTSTAR Local Consolidative Therapy with Brigatinib in Tyrosine Kinase Inhibitor-Naïve ALK-Rearranged Metastatic NSCLC
126. MA15.04 Timing of Pre-Biopsy COVID-mRNA Vaccination and PD-L1 Expression in Advanced Non-Small Cell Lung Cancer
127. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
128. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women
129. Early Foley catheter removal in thoracic surgical oncology patients receiving epidural analgesia
130. Does cramming work? Impact of National Web-Based Thoracic Surgery Curriculum login frequency on thoracic surgery in-training exam performance
131. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma
132. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components
133. Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer
134. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients
135. Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer
136. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer
137. Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells
138. Predictors of the response of operating room personnel to surgeon behaviors
139. 277 Combined neoadjuvant chemo-immunotherapy therapy achieves superior downstaging of resectable non-small cell lung cancer as compared to chemotherapy, mono or dual immunotherapy
140. Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
141. Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
142. ATM Mutations Associate with Distinct Co-Mutational Patterns and Therapeutic Vulnerabilities in NSCLC
143. Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases
144. Circulomic variables predict pathologic staging preoperatively in treatment-naïve non-small cell lung cancer
145. Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer
146. Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma
147. Impact of travel distance on receipt of indicated adjuvant therapy in resected non–small cell lung cancer
148. Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival
149. Discussion
150. Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.